サイクリンD2
PMC 3455455. PMID 11209538. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3455455/.
“Cutting edge: differential signaling requirements for activation of assembled cyclin D3-cdk4 complexes in B-1 and B-2 lymphocyte subsets”. Journal of Immunology 166 (7): 4273–7. (Apr 2001). doi:10.4049/jimmunol.166.7.4273. PMID 11254678.
“The expression of pseudogene cyclin D2 mRNA in the human ovary may be a novel marker for decreased ovarian function associated with the aging process”. Journal of Assisted Reproduction and Genetics 18 (2): 110–3. (Feb 2001). doi:10.1023/A:1026538826392. PMC 3455561. PMID 11285977. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3455561/.
Journal of Neurochemistry 70 (1): 335–40. (Jan 1998). doi:10.1046/j.1471-4159.1998.70010335.x. PMID 9422379.
“Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo”. Molecular and Cellular Biology 19 (1): 353–63. (Jan 1999). doi:10.1128/mcb.19.1.353. PMC 83893. PMID 9858559. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC83893/.
“D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy”. The Journal of Pathology 187 (5): 573–81. (Apr 1999). doi:10.1002/(SICI)1096-9896(199904)187:5<573::AID-PATH289>3.0.CO;2-H. PMID 10398124.